Compare Dwi Guna Laksana Tbk. (DWGL) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dwi Guna Laksana Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Dwi Guna Laksana Tbk. trades at Rp356 (market cap 3.52T, 7.1M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Dwi Guna Laksana Tbk. is far larger — about 21.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Dwi Guna Laksana Tbk. is more actively traded (7.1M versus 187.4K). Which is the better fit depends on your goals.
| DWGL | OBAT | |
|---|---|---|
Market Cap | 3.52T | 164.65B |
Volume | 7.1M | 187.4K |
Lot | 71.04K | 1.87K |
Turnover | 2.62B | 44.35M |
Average Price | 368.33 | 236.67 |
Value | 2.62B | 44.35M |
Indicative Equilibrium Price | 356 | 242 |
Indicative Equilibrium Volume | 2.26K | 500 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dwi Guna Laksana Tbk.
PT Dwi Guna Laksana Tbk (the Company) was established based on Notarial Deed No. 4 dated November 10, 1986 of Cornelia Juanda Tanuraharja, SH., a public notary in Surakarta.
Read more on DWGL →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
